| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for MRK from our risk checks.
Merck KGaA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €168.50 |
| 52 Week High | €172.40 |
| 52 Week Low | €134.30 |
| Beta | 0.69 |
| 1 Month Change | 14.08% |
| 3 Month Change | 7.26% |
| 1 Year Change | 2.71% |
| 3 Year Change | 14.43% |
| 5 Year Change | 92.31% |
| Change since IPO | 986.46% |
Recent News & Updates
Merck KGaA's (ETR:MRK) Intrinsic Value Is Potentially 48% Above Its Share Price
May 22
Merck KGaA (ETR:MRK) Will Pay A Dividend Of €2.20
Apr 26Merck KGaA (ETR:MRK) Is Paying Out A Dividend Of €2.20
Apr 04Recent updates
Merck KGaA's (ETR:MRK) Intrinsic Value Is Potentially 48% Above Its Share Price
May 22Merck KGaA (ETR:MRK) Will Pay A Dividend Of €2.20
Apr 26Merck KGaA (ETR:MRK) Is Paying Out A Dividend Of €2.20
Apr 04Merck KGaA (ETR:MRK) Has Affirmed Its Dividend Of €2.20
Mar 18We Think Merck KGaA (ETR:MRK) Can Stay On Top Of Its Debt
Feb 07There's Reason For Concern Over Merck KGaA's (ETR:MRK) Price
Jan 17Merck KGaA's (ETR:MRK) Intrinsic Value Is Potentially 77% Above Its Share Price
Dec 27Does Merck KGaA (ETR:MRK) Have A Healthy Balance Sheet?
Oct 10Is There An Opportunity With Merck KGaA's (ETR:MRK) 49% Undervaluation?
Sep 13Is Merck KGaA (ETR:MRK) A Risky Investment?
Jun 30Are Investors Undervaluing Merck KGaA (ETR:MRK) By 36%?
Jun 09These 4 Measures Indicate That MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Is Using Debt Reasonably Well
Mar 26MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Dividend Will Be Increased To €2.20
Mar 05Estimating The Intrinsic Value Of MERCK Kommanditgesellschaft auf Aktien (ETR:MRK)
Feb 14We Think MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Can Stay On Top Of Its Debt
Dec 12Is MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Trading At A 50% Discount?
Nov 09Does MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Have A Healthy Balance Sheet?
Aug 15Does MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Have A Healthy Balance Sheet?
May 17MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Dividend Will Be Increased To €1.85
Mar 29Is MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) A Risky Investment?
Jan 13We Think MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Can Manage Its Debt With Ease
Oct 15A Look At The Intrinsic Value Of MERCK Kommanditgesellschaft auf Aktien (ETR:MRK)
Sep 19MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Seems To Use Debt Quite Sensibly
Jul 11MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Intrinsic Value Is Potentially 58% Above Its Share Price
Jun 21These 4 Measures Indicate That MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Is Using Debt Reasonably Well
Apr 03Do Institutions Own MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Shares?
Mar 16Should Weakness in MERCK Kommanditgesellschaft auf Aktien's (ETR:MRK) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Mar 01Shareholder Returns
| MRK | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 1.6% | 2.3% | -0.9% |
| 1Y | 2.7% | -20.4% | 4.5% |
Return vs Industry: MRK exceeded the German Pharmaceuticals industry which returned -20.4% over the past year.
Return vs Market: MRK underperformed the German Market which returned 4.5% over the past year.
Price Volatility
| MRK volatility | |
|---|---|
| MRK Average Weekly Movement | 3.4% |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: MRK has not had significant price volatility in the past 3 months.
Volatility Over Time: MRK's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1668 | 62,345 | Belen Garijo Lopez | www.emdgroup.com |
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Merck KGaA Fundamentals Summary
| MRK fundamental statistics | |
|---|---|
| Market cap | €73.26b |
| Earnings (TTM) | €2.72b |
| Revenue (TTM) | €20.82b |
26.9x
P/E Ratio3.5x
P/S RatioIs MRK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MRK income statement (TTM) | |
|---|---|
| Revenue | €20.82b |
| Cost of Revenue | €8.70b |
| Gross Profit | €12.12b |
| Other Expenses | €9.40b |
| Earnings | €2.72b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 01, 2024
| Earnings per share (EPS) | 6.26 |
| Gross Margin | 58.23% |
| Net Profit Margin | 13.07% |
| Debt/Equity Ratio | 35.5% |
How did MRK perform over the long term?
See historical performance and comparison